Lilly Exploring Strategic Alternatives for Animal Health Biz Post author:Sam Post published:January 31, 2018 Post category:BioPharma Sluggish growth is the main driver for the decision.. Source: BioSpace You Might Also Like Cambrex Corporation Reports Second Quarter 2017 Financial Results August 3, 2017 bluebird bio Touts Impressive Data From Late-Stage Gene Therapy Study June 22, 2017 Merck KGaA to Shutter Four Sites, Lay Off 200 Employees July 12, 2017